SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

NCT02008877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Malignant Peripheral Nerve Sheath Tumors (MPNST)
Sarcoma

Interventions

DRUG: ganetespib
DRUG: Sirolimus

Sponsor

Sarcoma Alliance for Research through Collaboration

Collaborators

[object Object]
[object Object]